HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Harkin interested in FDA use of foreign marketing data to support U.S. availability.

This article was originally published in The Rose Sheet

Executive Summary

REP. HARKIN CONSIDERING LEGISLATION ON FDA USE OF FOREIGN MARKETING DATA if the agency does not change its policy on the issue. At a May 22 session of the First International Congress on Alternative and Complementary Medicine, Sen. Tom Harkin's (D-IA) Legislative Director Peter Reinecke said the senator "has been working on the issue" of FDA "prohibiting the consideration of foreign use data relative to drugs" during the "process for their review for FDA approval."
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001701

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel